
Diabetes remission & fatty liver program
Type 2 diabetes remission means HbA1c stays below 6.5% for at least three months after glucose-lowering medicines are stopped. It is most achievable early in the disease with substantial, sustained weight loss, and liver fat and inflammation tend to improve in proportion to weight lost. It is not a cure: glucose can rise again, so monitoring continues.
Every treatment starts with a proper assessment. A clinician reviews your case before anything is recommended.
Conditions treated
What it is & how it works
A physician-led program for early type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD, the 2023 name for non-alcoholic fatty liver disease). It combines diagnostics, structured nutrition and weight-management support, and physician-managed medication changes. The evidence base: in the DiRECT trial, 46% of people with type 2 diabetes diagnosed within the previous six years reached remission at 12 months on an intensive weight-management programme, versus 4% with usual care, and remission tracked closely with weight lost. In fatty liver, a 52-week study of 293 people with biopsy-proven steatohepatitis found the greatest improvements in those who lost at least 10% of body weight.
How it's done
Begins with diagnostic assessment (HbA1c and related glucose markers, liver enzymes, and imaging such as ultrasound or FibroScan where indicated), followed by an individualized nutrition and lifestyle plan, medication management by a physician where appropriate, and regular follow-up (commonly monthly) to track lab markers over a program that typically runs several months to a year depending on goals and starting severity.
Why Unfold Longevity
Remission is defined and tracked against the internationally agreed criterion (HbA1c below 6.5% at least three months after stopping glucose-lowering drugs), not by how you feel. Medication is reduced only by a physician against lab results, and liver progress is followed with liver enzymes and imaging such as ultrasound or FibroScan where indicated.
Evidence & safety
Remission is not guaranteed and is not a cure. It is less likely the longer diabetes has been present, and type 2 diabetes can return, so HbA1c is rechecked at least annually even after remission. Medicines are never stopped without physician supervision, people on insulin or with advanced liver disease need individual review, and this program complements rather than replaces care from your existing diabetes or liver specialist.
Related questions
Can type 2 diabetes be reversed?
Doctors use the term remission rather than reversal: HbA1c below 6.5% for at least three months after stopping glucose-lowering medicines. In the DiRECT trial, 46% of people diagnosed within six years achieved remission at one year with intensive weight management, versus 4% with usual care. It is not guaranteed, and diabetes can return.
Who is most likely to achieve diabetes remission?
Evidence points to people diagnosed relatively recently (DiRECT enrolled people within six years of diagnosis), who are not on insulin and who achieve and keep substantial weight loss. In DiRECT, remission rates rose with the amount of weight lost. Longer-standing diabetes or insulin use makes remission less likely, though markers can still improve.
Can fatty liver disease be reversed?
Liver fat and inflammation can improve with weight loss, and more weight loss brings more improvement. In a 52-week study of 293 people with biopsy-proven steatohepatitis, the highest rates of resolution and fibrosis regression occurred in those who lost at least 10% of body weight. Advanced scarring (cirrhosis) needs specialist hepatology care.
Do I have to stop my diabetes medicines?
Never on your own. Any reduction is made by a physician, step by step, against your glucose and HbA1c results, because stopping medicines without supervision can cause dangerous high blood sugar. Some people reduce or stop medicines over the program; others continue them with better control. Both are acceptable outcomes.
How long does the program take?
Most programs run several months to a year, with follow-up commonly every month. Remission can only be confirmed with an HbA1c test at least three months after glucose-lowering medicines are stopped, and it should be rechecked at least once a year after that.
Is this program safe for everyone?
Not without assessment. People on insulin or sulfonylureas, with advanced kidney or liver disease, eating disorders, pregnancy, or diabetic eye disease need individual review before intensive diet changes or medication reduction. These are screened at the first visit, and the plan is adjusted or coordinated with your existing specialists.
Care is individualized and outcomes vary between patients.







